HistCite - Hayflick w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
9901	7209 TSUKADA T, TOMOOKA Y, TAKAI S, UEDA Y, NISHIKAWA S, et al. ENHANCED PROLIFERATIVE POTENTIAL IN CULTURE OF CELLS FROM P53-DEFICIENT MICE ONCOGENE. 1993 DEC; 8 (12): 3313-3322	14	261	8	55
9902	7283 MACLEAN K, ROGAN EM, WHITAKER NJ, CHANG ACM, ROWE PB, et al. IN-VITRO TRANSFORMATION OF LI-FRAUMENI SYNDROME FIBROBLASTS BY SV40 LARGE T-ANTIGEN MUTANTS ONCOGENE. 1994 MAR; 9 (3): 719-725	17	25	11	41
9903	7298 HERBER B, TRUSS M, BEATO M, MULLER R INDUCIBLE REGULATORY ELEMENTS IN THE HUMAN CYCLIN-D1 PROMOTER ONCOGENE. 1994 APR; 9 (4): 1295-1304	3	222	1	46
9904	7335 BOND JA, WYLLIE FS, WYNFORDTHOMAS D ESCAPE FROM SENESCENCE IN HUMAN-DIPLOID FIBROBLASTS INDUCED DIRECTLY BY MUTANT P53 ONCOGENE. 1994 JUL; 9 (7): 1885-1889	76	154	8	18
9905	7370 WOODS C, LEFEUVRE C, STEWART N, BACCHETTI S INDUCTION OF GENOMIC INSTABILITY IN SV40-TRANSFORMED HUMAN-CELLS - SUFFICIENCY OF THE N-TERMINAL-147 AMINO-ACIDS OF LARGE T-ANTIGEN AND ROLE OF PRB AND P53 ONCOGENE. 1994 OCT; 9 (10): 2943-2950	1	42	13	78
9906	7458 TAHARA H, SATO E, NODA A, IDE T INCREASE IN EXPRESSION LEVEL OF P21(SDI1/CIP1/WAF1) WITH INCREASING DIVISION AGE IN BOTH NORMAL AND SV40-TRANSFORMED HUMAN FIBROBLASTS ONCOGENE. 1995 MAR 2; 10 (5): 835-840	47	103	11	19
9907	7459 ONEILL FJ, FRISQUE RJ, XU XL, HU YX, CARNEY H IMMORTALIZATION OF HUMAN-CELLS BY MUTANT AND CHIMERIC PRIMATE POLYOMAVIRUS T-ANTIGEN GENES ONCOGENE. 1995 MAR 16; 10 (6): 1131-1139	1	10	14	66
9908	7534 FUJII M, IDE T, WADHWA R, TAHARA H, KAUL SC, et al. INHIBITORS OF CGMP-DEPENDENT PROTEIN-KINASE BLOCK SENESCENCE INDUCED BY INACTIVATION OF T-ANTIGEN IN SV40-TRANSFORMED IMMORTAL HUMAN FIBROBLASTS ONCOGENE. 1995 AUG 17; 11 (4): 627-634	9	26	14	45
9909	7558 CHADENEAU C, SIEGEL P, HARLEY CB, MULLER WJ, BACCHETTI S TELOMERASE ACTIVITY IN NORMAL AND MALIGNANT MURINE TISSUES ONCOGENE. 1995 SEP 7; 11 (5): 893-898	26	120	9	37
9910	7559 WHITAKER NJ, BRYAN TM, BONNEFIN P, CHANG ACM, MUSGROVE EA, et al. INVOLVEMENT OF RB-1, P53, P16(INK4) AND TELOMERASE IN IMMORTALIZATION OF HUMAN-CELLS ONCOGENE. 1995 SEP 7; 11 (5): 971-976	33	76	12	41
#	Date / Author / Journal	LCS	GCS	LCR	CR
9911	7562 TAHARA H, KAMADA K, SATO E, TSUYAMA N, KIM JK, et al. INCREASE IN EXPRESSION LEVELS OF INTERFERON-INDUCIBLE GENES IN SENESCENT HUMAN-DIPLOID FIBROBLASTS AND IN SV40-TRANSFORMED HUMAN FIBROBLASTS WITH EXTENDED LIFE-SPAN ONCOGENE. 1995 SEP 21; 11 (6): 1125-1132	12	27	27	49
9912	7644 Sandhu AK, Kaur GP, Reddy DE, Rane NS, Athwal RS A gene on 6q 14-21 restores senescence to immortal ovarian tumor cells ONCOGENE. 1996 JAN 18; 12 (2): 247-252	11	53	11	44
9913	7708 Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G Telomerase activity in human renal cell carcinoma ONCOGENE. 1996 JUL 4; 13 (1): 161-166	13	93	7	40
9914	7739 Noble JR, Rogan EM, Neumann AA, Maclean K, Bryan TM, et al. Association of extended in vitro proliferative potential with loss of p16(INK4) expression ONCOGENE. 1996 SEP 19; 13 (6): 1259-1268	23	51	15	61
9915	7798 Banga SS, Kim S, Hubbard K, Dasgupta T, Jha KK, et al. SEN6, a locus for SV40-mediated immortalization of human cells, maps to 6q26-27 ONCOGENE. 1997 JAN 23; 14 (3): 313-321	17	59	19	68
9916	7848 Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, et al. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes ONCOGENE. 1997 APR 24; 14 (16): 1955-1964	15	58	23	48
9917	7882 Zindy F, Quelle DE, Roussel MF, Sherr CJ Expression of the p16(INK4a) tumor suppressor versus other INK4 family members during mouse development and aging ONCOGENE. 1997 JUL 10; 15 (2): 203-211	51	292	5	49
9918	7931 Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, et al. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus ONCOGENE. 1997 OCT 16; 15 (16): 1911-1920	19	98	5	36
9919	7956 Xu HJ, Zhou YL, Ji W, Perng GS, Kruzelock R, et al. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition ONCOGENE. 1997 NOV 20; 15 (21): 2589-2596	38	112	11	37
9920	8143 Erickson S, Sangfelt O, Heyman M, Castro J, Einhorn S, et al. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence ONCOGENE. 1998 AUG 6; 17 (5): 595-602	14	58	10	44
#	Date / Author / Journal	LCS	GCS	LCR	CR
9921	8148 Kaul SC, Duncan EL, Englezou A, Takano S, Reddel RR, et al. Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein ONCOGENE. 1998 AUG 20; 17 (7): 907-911	6	48	16	31
9922	8163 Ma L, Broomfield S, Lavery C, Lin SL, Xiao W, et al. Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines ONCOGENE. 1998 SEP 10; 17 (10): 1321-1326	1	15	13	34
9923	8209 Russo I, Silver ARJ, Cuthbert AP, Griffin DK, Trott DA, et al. A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization ONCOGENE. 1998 DEC 31; 17 (26): 3417-3426	13	33	17	62
9924	8245 Duncan EL, Reddel RR Downregulation of metallothionein-IIA expression occurs at immortalization ONCOGENE. 1999 JAN 28; 18 (4): 897-903	2	18	15	42
9925	8254 Falchetti ML, Falcone G, D'Ambrosio E, Verna R, Alema S, et al. Induction of telomerase activity in v-myc-transformed avian cells ONCOGENE. 1999 FEB 18; 18 (7): 1515-1519	3	21	9	49
9926	8344 Ducray C, Pommier JP, Martins L, Boussin FD, Sabatier L Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process ONCOGENE. 1999 JUL 22; 18 (29): 4211-4223	18	82	13	44
9927	8363 Chang BD, Xuan YZ, Broude EV, Zhu HM, Schott B, et al. Role of p53 and p21(waf1/cip1) in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs ONCOGENE. 1999 AUG 26; 18 (34): 4808-4818	33	164	14	43
9928	8372 Reddy DE, Sandhu AK, DeRiel JK, Athwal RS, Kaur GP Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells ONCOGENE. 1999 SEP 9; 18 (36): 5100-5107	8	17	18	64
9929	8402 Shammas MA, Simmons CG, Corey DR, Reis RJS Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells ONCOGENE. 1999 NOV 4; 18 (46): 6191-6200	15	103	19	52
9930	8417 Powell AJ, Darmon AJ, Gonos ES, Lam EWF, Peden KWC, et al. Different functions are required for initiation and maintenance of immortalization of rat embryo fibroblasts by SV40 large T antigen ONCOGENE. 1999 DEC 2; 18 (51): 7343-7350	4	18	9	56
#	Date / Author / Journal	LCS	GCS	LCR	CR
9931	8419 Vaziri H, Benchimol S Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase ONCOGENE. 1999 DEC 13; 18 (53): 7676-7680	8	28	24	70
9932	8527 Yang XH, He ZM, Xin BZ, Cao L LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16(INK4a) expression ONCOGENE. 2000 APR 13; 19 (16): 2002-2013	6	38	15	70
9933	8629 Sheng ZJ, Sun WP, Smith E, Cohen C, Sheng Z, et al. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells ONCOGENE. 2000 OCT 5; 19 (42): 4847-4854	0	49	2	36
9934	8644 Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, et al. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells ONCOGENE. 2000 NOV 9; 19 (47): 5314-5323	2	27	18	71
9935	8705 Wood LD, Halvorsen TL, Dhar S, Baur JA, Pandita RK, et al. Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression ONCOGENE. 2001 JAN 18; 20 (3): 278-288	13	55	10	65
9936	8766 Kim H, You SK, Kim IJ, Foster LK, Farris J, et al. Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts ONCOGENE. 2001 MAY 10; 20 (21): 2671-2682	7	26	10	36
9937	8789 Munro J, Steeghs K, Morrison V, Ireland H, Parkinson EK Human fibroblast replicative senescence can occur in the absence of extensive cell division and short telomeres ONCOGENE. 2001 JUN 14; 20 (27): 3541-3552	12	29	27	49
9938	8847 Jung MS, Yun J, Chae HD, Kim JM, Kim SC, et al. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor ONCOGENE. 2001 SEP 13; 20 (41): 5818-5825	7	48	8	58
9939	8865 Pearson M, Pelicci PG PML interaction with p53 and its role in apoptosis and replicative senescence ONCOGENE. 2001 OCT 29; 20 (49): 7250-7256	6	69	10	96
9940	8900 Schwarze SR, Shi Y, Fu VX, Watson PA, Jarrard DF Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells ONCOGENE. 2001 DEC 13; 20 (57): 8184-8192	7	41	20	57
#	Date / Author / Journal	LCS	GCS	LCR	CR
9941	8902 Zebedee Z, Hara E Id proteins in cell cycle control and cellular senescence ONCOGENE. 2001 DEC 20; 20 (58): 8317-8325	1	115	23	113
9942	8949 Toouli CD, Huschtscha LI, Neumann AA, Noble JR, Colgin LM, et al. Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit ONCOGENE. 2002 JAN 3; 21 (1): 128-139	6	41	13	59
9943	8953 Stewart SA, Weinberg RA Senescence: does it all happen at the ends? ONCOGENE. 2002 JAN 21; 21 (4): 627-630	9	42	24	47
9944	8955 Gao YN, Lu YJ, Xue SA, Chen HL, Wedderburn N, et al. Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus ONCOGENE. 2002 JAN 24; 21 (5): 825-835	0	11	5	68
9945	8969 Djelloul S, Tarunina M, Barnouin K, Mackay A, Jat PS Differential protein expression, DNA binding and interaction with SV40 large tumour antigen implicate the p63-family of proteins in replicative senescence ONCOGENE. 2002 FEB 7; 21 (7): 981-989	1	14	10	33
9946	9023 Krause DS Regulation of hematopoietic stem cell fate ONCOGENE. 2002 MAY 13; 21 (21): 3262-3269	0	36	1	68
9947	9024 Allsopp RC, Weissman IL Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role? ONCOGENE. 2002 MAY 13; 21 (21): 3270-3273	8	37	15	52
9948	9048 MacKenzie KL, Franco S, Naiyer AJ, May C, Sadelain M, et al. Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras ONCOGENE. 2002 JUN 20; 21 (27): 4200-4211	9	39	13	55
9949	9068 Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, et al. Immortalization and transformation of primary human airway epithelial cells by gene transfer ONCOGENE. 2002 JUL 4; 21 (29): 4577-4586	16	103	11	44
9950	9212 Yawata T, Kamino H, Kugoh H, Katoh M, Nomura N, et al. Identification of a <= 600-kb region on human chromosome 1q42.3 inducing cellular senescence ONCOGENE. 2003 JAN 16; 22 (2): 281-290	1	5	21	49
#	Date / Author / Journal	LCS	GCS	LCR	CR
9951	9289 Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, et al. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization ONCOGENE. 2003 JUN 26; 22 (26): 4118-4127	12	68	11	49
9952	9306 Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence ONCOGENE. 2003 JUL 31; 22 (31): 4831-4840	2	44	9	51
9953	9448 Mallette FA, Goumard S, Gaumont-Leclerc MF, Moiseeva O, Ferbeyre G Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence ONCOGENE. 2004 JAN 8; 23 (1): 91-99	8	37	18	53
9954	9498 Shay JW, Roninson IB Hallmarks of senescence in carcinogenesis and cancer therapy ONCOGENE. 2004 APR 12; 23 (16): 2919-2933	56	184	44	160
9955	9501 Noble JR, Zhong ZH, Neumann AA, Melki JR, Clark SJ, et al. Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT- immortalized human fibroblasts ONCOGENE. 2004 APR 15; 23 (17): 3116-3121	7	30	23	44
9956	9577 Tang XH, Milyavsky M, Shats I, Erez N, Goldfinger N, et al. Activated p53 suppresses the histone methyltransferase EZH2 gene ONCOGENE. 2004 JUL 29; 23 (34): 5759-5769	1	60	15	66
9957	9594 Zhang H, Herbert BS, Pan KH, Shay JW, Cohen SN Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions ONCOGENE. 2004 AUG 19; 23 (37): 6193-6198	4	11	20	40
9958	9595 Xin H, Pereira-Smith OM, Choubey D Role of IFI 16 in cellular senescence of human fibroblasts ONCOGENE. 2004 AUG 19; 23 (37): 6209-6217	3	27	13	44
9959	9596 Bocchetta M, Carbone M Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation ONCOGENE. 2004 AUG 23; 23 (38): 6484-6491	0	13	12	74
9960	9608 Warner JK, Wang JCY, Hope KJ, Jin LQ, Dick JE Concepts of human leukemic development ONCOGENE. 2004 SEP 20; 23 (43): 7164-7177	1	107	5	153
#	Date / Author / Journal	LCS	GCS	LCR	CR
9961	9663 Mason DX, Jackson TJ, Lin AW Molecular signature of oncogenic ras-induced senescence ONCOGENE. 2004 DEC 9; 23 (57): 9238-9246	10	38	22	62
9962	9704 Kaur GP, Reddy DE, Zimonjic DB, de Riel JK, Athwal RS Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells ONCOGENE. 2005 JAN 6; 24 (1): 47-54	0	2	10	44
9963	9705 Delgado JP, Parouchev A, Allain JE, Pennarun L, Gauthier LR, et al. Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer ONCOGENE. 2005 JAN 20; 24 (4): 541-551	0	14	12	54
9964	9931 Tsuda M, Watanabe T, Seki T, Kimura T, Sawa H, et al. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1 ONCOGENE. 2005 DEC 1; 24 (54): 7984-7990	0	9	7	27
9965	10143 Helmbold H, Deppert W, Bohn W Regulation of cellular senescence by Rb2/p130 ONCOGENE. 2006 AUG 28; 25 (38): 5257-5262	4	12	10	92
9966	10190 Macip S, Kosoy A, Lee SW, O'Connell MJ, Aaronson SA Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G(2) checkpoint ONCOGENE. 2006 OCT 5; 25 (45): 6037-6047	1	17	18	81
9967	10356 Yang G, Rosen DG, Colacino JA, Mercado-Uribe I, Liu J Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells ONCOGENE. 2007 MAR 1; 26 (10): 1492-1498	0	8	5	41
9968	10402 Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, et al. Role of 2-5A-dependent RNase-L in senescence and longevity ONCOGENE. 2007 MAY 10; 26 (21): 3081-3088	0	6	10	41
9969	10568 Quereda V, Martinalbo J, Dubus P, Carnero A, Malumbres M Genetic cooperation between p21(Cip1) and INK4 inhibitors in cellular senescence and tumor suppression ONCOGENE. 2007 DEC 6; 26 (55): 7665-7674	2	15	11	60
9970	10670 Michaloglou C, Vredeveld LCW, Mooi WJ, Peeper DS BRAF(E600) in benign and malignant human tumours ONCOGENE. 2008 FEB 7; 27 (7): 877-895	4	58	12	209
#	Date / Author / Journal	LCS	GCS	LCR	CR
9971	10881 Fridman AL, Tainsky MA Critical pathways in cellular senescence and immortalization revealed by gene expression profiling ONCOGENE. 2008 OCT 9; 27 (46): 5975-5987	10	36	59	129
9972	11094 Tilman G, Loriot A, Van Beneden A, Arnoult N, Londono-Vallejo JA, et al. Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells ONCOGENE. 2009 APR 9; 28 (14): 1682-1693	1	10	3	49
9973	11169 Wolyniec K, Wotton S, Kilbey A, Jenkins A, Terry A, et al. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress ONCOGENE. 2009 JUL 9; 28 (27): 2502-2512	2	7	5	40
9974	11217 Sporn JC, Kustatscher G, Hothorn T, Collado M, Serrano M, et al. Histone macroH2A isoforms predict the risk of lung cancer recurrence ONCOGENE. 2009 SEP 24; 28 (38): 3423-3428	1	11	5	18
9975	11363 Lee JJ, Lee JH, Ko YG, Hong SI, Lee JS Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species ONCOGENE. 2010 JAN; 29 (4): 561-575	1	4	11	67
9976	11373 Novakova Z, Hubackova S, Kosar M, Janderova-Rossmeislova L, Dobrovolna J, et al. Cytokine expression and signaling in drug-induced cellular senescence ONCOGENE. 2010 JAN 14; 29 (2): 273-284	2	11	17	50
9977	11437 Varela E, Blasco MA 2009 Nobel Prize in Physiology or Medicine: telomeres and telomerase ONCOGENE. 2010 MAR 18; 29 (11): 1561-1565	0	2	9	83
9978	11800 Das SK, Bhutia SK, Sokhi UK, Dash R, Azab B, et al. Human polynucleotide phosphorylase (hPNPaseold(35)): an evolutionary conserved gene with an expanding repertoire of RNA degradation functions ONCOGENE. 2011 APR; 30 (15): 1733-1743	0	0	10	98
9979	11827 Romagosa C, Simonetti S, Lopez-Vicente L, Mazo A, Lleonart ME, et al. p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors ONCOGENE. 2011 MAY; 30 (18): 2087-2097	0	0	16	136
9980	11828 Rovillain E, Mansfield L, Caetano C, Alvarez-Fernandez M, Caballero OL, et al. Activation of nuclear factor-kappa B signalling promotes cellular senescence ONCOGENE. 2011 MAY; 30 (20): 2356-2366	0	0	14	54
#	Date / Author / Journal	LCS	GCS	LCR	CR
9981	11848 Crescenzi E, Pacifico F, Lavorgna A, De Palma R, D'Aiuto E, et al. NF-kappa B-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells ONCOGENE. 2011 JUN; 30 (24): 2707-2717	0	0	9	39
9982	11849 Lanigan F, Geraghty JG, Bracken AP Transcriptional regulation of cellular senescence ONCOGENE. 2011 JUN; 30 (26): 2901-2911	0	0	21	149
9983	5984 VOGT M, LESLEY J, BOGENBERGER JM, HAGGBLOM C, SWIFT S, et al. THE INDUCTION OF GROWTH FACTOR-INDEPENDENCE IN MURINE MYELOCYTES BY ONCOGENES RESULTS IN MONOCLONAL CELL-LINES AND IS CORRELATED WITH CELL CRISIS AND KARYOTYPIC INSTABILITY ONCOGENE RESEARCH. 1987; 2 (1): 49-63	1	23	3	19
9984	6323 OWEN TA, COSENZA SC, SOPRANO DR, SOPRANO KJ EVIDENCE THAT STIMULATION OF GROWTH FOLLOWING LONG-TERM DENSITY ARREST OF WI-38 CELLS PROCEEDS VIA A PATHWAY INDEPENDENT OF PROTEIN KINASE-C AND OF CAMP-DEPENDENT PROTEIN-KINASE ONCOGENE RESEARCH. 1989; 4 (2): 137-147	0	2	4	28
9985	7413 KILLARY AM, FOURNIER REK MICROCELL FUSION ONCOGENE TECHNIQUES. 1995; 254: 133-152	0	17	5	42
9986	10051 Ricci MS, Zong WX Chemotherapeutic approaches for targeting cell death pathways ONCOLOGIST. 2006 APR; 11 (4): 342-357	0	74	7	184
9987	2237 MOREK DM ORGAN-CULTURE STUDY OF FROG RENAL TUMOR AND ITS EFFECTS ON NORMAL FROG KIDNEY IN-VITRO ONCOLOGY. 1973; 28 (6): 536-552	0	4	1	25
9988	4349 DANES BS HERITABLE COLONIC-CANCER SYNDROMES - INDUCTION OF ANCHORAGE- INDEPENDENCE IN DERMAL CULTURES DERIVED FROM PATIENTS WITH ADENOMATOSIS OF THE COLON AND RECTUM ONCOLOGY. 1980; 37 (6): 386-389	0	8	1	20
9989	10395 Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, et al. Health Behaviors in Cancer Survivors ONCOLOGY NURSING FORUM. 2007 MAY; 34 (3): 643-651	0	6	1	71
9990	8155 Engelhardt M, Martens UM The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review) ONCOLOGY REPORTS. 1998 SEP-OCT; 5 (5): 1043-1052	4	25	16	109
#	Date / Author / Journal	LCS	GCS	LCR	CR
9991	9232 Pandita TK, Roti JLR Role of telomerase in radiocurability (Review) ONCOLOGY REPORTS. 2003 MAR-APR; 10 (2): 263-270	1	11	11	87
9992	10413 Minami K, Inoue H, Terashita T, Kawakami T, Watanabe R, et al. GADD34 induces p21 expression and cellular senescence ONCOLOGY REPORTS. 2007 JUN; 17 (6): 1481-1485	0	0	2	16
9993	11563 Kim BC, Han NK, Byun HO, Kim SS, Ahn EK, et al. Time-dependently expressed markers and the characterization for premature senescence induced by ionizing radiation in MCF7 ONCOLOGY REPORTS. 2010 AUG; 24 (2): 395-403	0	0	17	49
9994	7614 WynfordThomas D Telomeres, p53 and cellular senescence ONCOLOGY RESEARCH. 1996; 8 (10-11): 387-398	5	18	38	94
9995	6461 TRICHARD CJV, BASSON PA, VANDERLUGT JJ, JACOBSZ EP AN OUTBREAK OF CONTAGIOUS BOVINE PLEUROPNEUMONIA IN THE OWAMBO MANGETTI AREA OF SOUTH-WEST-AFRICA NAMIBIA - MICROBIOLOGICAL, IMMUNOFLUORESCENT, PATHOLOGICAL AND SEROLOGICAL FINDINGS ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH. 1989 DEC; 56 (4): 277-284	0	7	3	25
9996	7079 TRICHARD CJV, JORDAAN P, PROZESKY L, JACOBSZ EP, HENTON MM THE IDENTIFICATION OF MYCOPLASMA-MYCOIDES-MYCOIDES LC AS THE ETIOLOGIC AGENT OF BALANOPOSTHITIS AND VULVO-VAGINITIS IN SHEEP IN SOUTH-AFRICA ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH. 1993 MAR; 60 (1): 29-37	0	6	3	14
9997	8715 Sasgary S, Wieser M, Cerni C Targeted inhibition of telomerase in human cancer: Will it be a double- edged sword? ONKOLOGIE. 2001 FEB; 24 (1): 22-26	0	2	9	37
9998	4031 VORNHAGEN R, RINK H INFLUENCE OF CULTURE CONDITIONS ON THE BEHAVIOR OF LENS EPITHELIAL- CELLS OPHTHALMIC RESEARCH. 1979; 11 (5-6): 288-292	0	3	2	13
9999	8543 Rohrbach JM, Riedinger C, Wild M, Partsch M Telomerase activity in uveal melanomas OPHTHALMOLOGE. 2000 MAY; 97 (5): 359-363	0	1	4	22
10000	8467 Bron AJ, Vrensen GFJM, Koretz J, Maraini G, Harding JJ The ageing lens OPHTHALMOLOGICA. 2000 JAN-FEB; 214 (1): 86-104	0	79	2	129

Date / Author / Journal

LCS

GCS

LCR

9901

7209 TSUKADA T, TOMOOKA Y, TAKAI S, UEDA Y, NISHIKAWA S, et al.

ENHANCED PROLIFERATIVE POTENTIAL IN CULTURE OF CELLS FROM P53-DEFICIENT MICE

ONCOGENE. 1993 DEC; 8 (12): 3313-3322

261

9902

7283 MACLEAN K, ROGAN EM, WHITAKER NJ, CHANG ACM, ROWE PB, et al.

IN-VITRO TRANSFORMATION OF LI-FRAUMENI SYNDROME FIBROBLASTS BY SV40 LARGE T-ANTIGEN MUTANTS

ONCOGENE. 1994 MAR; 9 (3): 719-725

9903

7298 HERBER B, TRUSS M, BEATO M, MULLER R

INDUCIBLE REGULATORY ELEMENTS IN THE HUMAN CYCLIN-D1 PROMOTER

ONCOGENE. 1994 APR; 9 (4): 1295-1304

222

9904

7335 BOND JA, WYLLIE FS, WYNFORDTHOMAS D

ESCAPE FROM SENESCENCE IN HUMAN-DIPLOID FIBROBLASTS INDUCED DIRECTLY BY MUTANT P53

ONCOGENE. 1994 JUL; 9 (7): 1885-1889

154

9905

7370 WOODS C, LEFEUVRE C, STEWART N, BACCHETTI S

INDUCTION OF GENOMIC INSTABILITY IN SV40-TRANSFORMED HUMAN-CELLS - SUFFICIENCY OF THE N-TERMINAL-147 AMINO-ACIDS OF LARGE T-ANTIGEN AND ROLE OF PRB AND P53

ONCOGENE. 1994 OCT; 9 (10): 2943-2950

9906

7458 TAHARA H, SATO E, NODA A, IDE T

INCREASE IN EXPRESSION LEVEL OF P21(SDI1/CIP1/WAF1) WITH INCREASING DIVISION AGE IN BOTH NORMAL AND SV40-TRANSFORMED HUMAN FIBROBLASTS

ONCOGENE. 1995 MAR 2; 10 (5): 835-840

103

9907

7459 ONEILL FJ, FRISQUE RJ, XU XL, HU YX, CARNEY H

IMMORTALIZATION OF HUMAN-CELLS BY MUTANT AND CHIMERIC PRIMATE POLYOMAVIRUS T-ANTIGEN GENES

ONCOGENE. 1995 MAR 16; 10 (6): 1131-1139

9908

7534 FUJII M, IDE T, WADHWA R, TAHARA H, KAUL SC, et al.

INHIBITORS OF CGMP-DEPENDENT PROTEIN-KINASE BLOCK SENESCENCE INDUCED BY INACTIVATION OF T-ANTIGEN IN SV40-TRANSFORMED IMMORTAL HUMAN FIBROBLASTS

ONCOGENE. 1995 AUG 17; 11 (4): 627-634

9909

7558 CHADENEAU C, SIEGEL P, HARLEY CB, MULLER WJ, BACCHETTI S

TELOMERASE ACTIVITY IN NORMAL AND MALIGNANT MURINE TISSUES

ONCOGENE. 1995 SEP 7; 11 (5): 893-898

120

9910

7559 WHITAKER NJ, BRYAN TM, BONNEFIN P, CHANG ACM, MUSGROVE EA, et al.

INVOLVEMENT OF RB-1, P53, P16(INK4) AND TELOMERASE IN IMMORTALIZATION OF HUMAN-CELLS

ONCOGENE. 1995 SEP 7; 11 (5): 971-976

Date / Author / Journal

LCS

GCS

LCR

9911

7562 TAHARA H, KAMADA K, SATO E, TSUYAMA N, KIM JK, et al.

INCREASE IN EXPRESSION LEVELS OF INTERFERON-INDUCIBLE GENES IN SENESCENT HUMAN-DIPLOID FIBROBLASTS AND IN SV40-TRANSFORMED HUMAN FIBROBLASTS WITH EXTENDED LIFE-SPAN

ONCOGENE. 1995 SEP 21; 11 (6): 1125-1132

9912

7644 Sandhu AK, Kaur GP, Reddy DE, Rane NS, Athwal RS

A gene on 6q 14-21 restores senescence to immortal ovarian tumor cells

ONCOGENE. 1996 JAN 18; 12 (2): 247-252

9913

7708 Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G

Telomerase activity in human renal cell carcinoma

ONCOGENE. 1996 JUL 4; 13 (1): 161-166

9914

7739 Noble JR, Rogan EM, Neumann AA, Maclean K, Bryan TM, et al.

Association of extended in vitro proliferative potential with loss of p16(INK4) expression

ONCOGENE. 1996 SEP 19; 13 (6): 1259-1268

9915

7798 Banga SS, Kim S, Hubbard K, Dasgupta T, Jha KK, et al.

SEN6, a locus for SV40-mediated immortalization of human cells, maps to 6q26-27

ONCOGENE. 1997 JAN 23; 14 (3): 313-321

9916

7848 Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, et al.

Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes

ONCOGENE. 1997 APR 24; 14 (16): 1955-1964

9917

7882 Zindy F, Quelle DE, Roussel MF, Sherr CJ

Expression of the p16(INK4a) tumor suppressor versus other INK4 family members during mouse development and aging

ONCOGENE. 1997 JUL 10; 15 (2): 203-211

292

9918

7931 Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, et al.

Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus

ONCOGENE. 1997 OCT 16; 15 (16): 1911-1920

9919

7956 Xu HJ, Zhou YL, Ji W, Perng GS, Kruzelock R, et al.

Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition

ONCOGENE. 1997 NOV 20; 15 (21): 2589-2596

112

9920

8143 Erickson S, Sangfelt O, Heyman M, Castro J, Einhorn S, et al.

Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence

ONCOGENE. 1998 AUG 6; 17 (5): 595-602

Date / Author / Journal

LCS

GCS

LCR

9921

8148 Kaul SC, Duncan EL, Englezou A, Takano S, Reddel RR, et al.

Malignant transformation of NIH3T3 cells by overexpression of mot-2 protein

ONCOGENE. 1998 AUG 20; 17 (7): 907-911

9922

8163 Ma L, Broomfield S, Lavery C, Lin SL, Xiao W, et al.

Up-regulation of CIR1/CROC1 expression upon cell immortalization and in tumor-derived human cell lines

ONCOGENE. 1998 SEP 10; 17 (10): 1321-1326

9923

8209 Russo I, Silver ARJ, Cuthbert AP, Griffin DK, Trott DA, et al.

A telomere-independent senescence mechanism is the sole barrier to Syrian hamster cell immortalization

ONCOGENE. 1998 DEC 31; 17 (26): 3417-3426

9924

8245 Duncan EL, Reddel RR

Downregulation of metallothionein-IIA expression occurs at immortalization

ONCOGENE. 1999 JAN 28; 18 (4): 897-903

9925

8254 Falchetti ML, Falcone G, D'Ambrosio E, Verna R, Alema S, et al.

Induction of telomerase activity in v-myc-transformed avian cells

ONCOGENE. 1999 FEB 18; 18 (7): 1515-1519

9926

8344 Ducray C, Pommier JP, Martins L, Boussin FD, Sabatier L

Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process

ONCOGENE. 1999 JUL 22; 18 (29): 4211-4223

9927

8363 Chang BD, Xuan YZ, Broude EV, Zhu HM, Schott B, et al.

Role of p53 and p21(waf1/cip1) in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs

ONCOGENE. 1999 AUG 26; 18 (34): 4808-4818

164

9928

8372 Reddy DE, Sandhu AK, DeRiel JK, Athwal RS, Kaur GP

Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells

ONCOGENE. 1999 SEP 9; 18 (36): 5100-5107

9929

8402 Shammas MA, Simmons CG, Corey DR, Reis RJS

Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells

ONCOGENE. 1999 NOV 4; 18 (46): 6191-6200

103

9930

8417 Powell AJ, Darmon AJ, Gonos ES, Lam EWF, Peden KWC, et al.

Different functions are required for initiation and maintenance of immortalization of rat embryo fibroblasts by SV40 large T antigen

ONCOGENE. 1999 DEC 2; 18 (51): 7343-7350

Date / Author / Journal

LCS

GCS

LCR

9931

8419 Vaziri H, Benchimol S

Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase

ONCOGENE. 1999 DEC 13; 18 (53): 7676-7680

9932

8527 Yang XH, He ZM, Xin BZ, Cao L

LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16(INK4a) expression

ONCOGENE. 2000 APR 13; 19 (16): 2002-2013

9933

8629 Sheng ZJ, Sun WP, Smith E, Cohen C, Sheng Z, et al.

Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells

ONCOGENE. 2000 OCT 5; 19 (42): 4847-4854

9934

8644 Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, et al.

Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells

ONCOGENE. 2000 NOV 9; 19 (47): 5314-5323

9935

8705 Wood LD, Halvorsen TL, Dhar S, Baur JA, Pandita RK, et al.

Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression

ONCOGENE. 2001 JAN 18; 20 (3): 278-288

9936

8766 Kim H, You SK, Kim IJ, Foster LK, Farris J, et al.

Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts

ONCOGENE. 2001 MAY 10; 20 (21): 2671-2682

9937

8789 Munro J, Steeghs K, Morrison V, Ireland H, Parkinson EK

Human fibroblast replicative senescence can occur in the absence of extensive cell division and short telomeres

ONCOGENE. 2001 JUN 14; 20 (27): 3541-3552

9938

8847 Jung MS, Yun J, Chae HD, Kim JM, Kim SC, et al.

p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor

ONCOGENE. 2001 SEP 13; 20 (41): 5818-5825

9939

8865 Pearson M, Pelicci PG

PML interaction with p53 and its role in apoptosis and replicative senescence

ONCOGENE. 2001 OCT 29; 20 (49): 7250-7256

9940

8900 Schwarze SR, Shi Y, Fu VX, Watson PA, Jarrard DF

Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells

ONCOGENE. 2001 DEC 13; 20 (57): 8184-8192

Date / Author / Journal

LCS

GCS

LCR

9941

8902 Zebedee Z, Hara E

Id proteins in cell cycle control and cellular senescence

ONCOGENE. 2001 DEC 20; 20 (58): 8317-8325

115

113

9942

8949 Toouli CD, Huschtscha LI, Neumann AA, Noble JR, Colgin LM, et al.

Comparison of human mammary epithelial cells immortalized by simian virus 40 T-Antigen or by the telomerase catalytic subunit

ONCOGENE. 2002 JAN 3; 21 (1): 128-139

9943

8953 Stewart SA, Weinberg RA

Senescence: does it all happen at the ends?

ONCOGENE. 2002 JAN 21; 21 (4): 627-630

9944

8955 Gao YN, Lu YJ, Xue SA, Chen HL, Wedderburn N, et al.

Hypothesis: a novel route for immortalization of epithelial cells by Epstein-Barr virus

ONCOGENE. 2002 JAN 24; 21 (5): 825-835

9945

8969 Djelloul S, Tarunina M, Barnouin K, Mackay A, Jat PS

Differential protein expression, DNA binding and interaction with SV40 large tumour antigen implicate the p63-family of proteins in replicative senescence

ONCOGENE. 2002 FEB 7; 21 (7): 981-989

9946

9023 Krause DS

Regulation of hematopoietic stem cell fate

ONCOGENE. 2002 MAY 13; 21 (21): 3262-3269

9947

9024 Allsopp RC, Weissman IL

Replicative senescence of hematopoietic stem cells during serial transplantation: does telomere shortening play a role?

ONCOGENE. 2002 MAY 13; 21 (21): 3270-3273

9948

9048 MacKenzie KL, Franco S, Naiyer AJ, May C, Sadelain M, et al.

Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras

ONCOGENE. 2002 JUN 20; 21 (27): 4200-4211

9949

9068 Lundberg AS, Randell SH, Stewart SA, Elenbaas B, Hartwell KA, et al.

Immortalization and transformation of primary human airway epithelial cells by gene transfer

ONCOGENE. 2002 JUL 4; 21 (29): 4577-4586

103

9950

9212 Yawata T, Kamino H, Kugoh H, Katoh M, Nomura N, et al.

Identification of a <= 600-kb region on human chromosome 1q42.3 inducing cellular senescence

ONCOGENE. 2003 JAN 16; 22 (2): 281-290

Date / Author / Journal

LCS

GCS

LCR

9951

9289 Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, et al.

Epigenetic silencing of multiple interferon pathway genes after cellular immortalization

ONCOGENE. 2003 JUN 26; 22 (26): 4118-4127

9952

9306 Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D

Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence

ONCOGENE. 2003 JUL 31; 22 (31): 4831-4840

9953

9448 Mallette FA, Goumard S, Gaumont-Leclerc MF, Moiseeva O, Ferbeyre G

Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence

ONCOGENE. 2004 JAN 8; 23 (1): 91-99

9954

9498 Shay JW, Roninson IB

Hallmarks of senescence in carcinogenesis and cancer therapy

ONCOGENE. 2004 APR 12; 23 (16): 2919-2933

184

160

9955

9501 Noble JR, Zhong ZH, Neumann AA, Melki JR, Clark SJ, et al.

Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT- immortalized human fibroblasts

ONCOGENE. 2004 APR 15; 23 (17): 3116-3121

9956

9577 Tang XH, Milyavsky M, Shats I, Erez N, Goldfinger N, et al.

Activated p53 suppresses the histone methyltransferase EZH2 gene

ONCOGENE. 2004 JUL 29; 23 (34): 5759-5769

9957

9594 Zhang H, Herbert BS, Pan KH, Shay JW, Cohen SN

Disparate effects of telomere attrition on gene expression during replicative senescence of human mammary epithelial cells cultured under different conditions

ONCOGENE. 2004 AUG 19; 23 (37): 6193-6198

9958

9595 Xin H, Pereira-Smith OM, Choubey D

Role of IFI 16 in cellular senescence of human fibroblasts

ONCOGENE. 2004 AUG 19; 23 (37): 6209-6217

9959

9596 Bocchetta M, Carbone M

Epidemiology and molecular pathology at crossroads to establish causation: molecular mechanisms of malignant transformation

ONCOGENE. 2004 AUG 23; 23 (38): 6484-6491

9960

9608 Warner JK, Wang JCY, Hope KJ, Jin LQ, Dick JE

Concepts of human leukemic development

ONCOGENE. 2004 SEP 20; 23 (43): 7164-7177

107

153

Date / Author / Journal

LCS

GCS

LCR

9961

9663 Mason DX, Jackson TJ, Lin AW

Molecular signature of oncogenic ras-induced senescence

ONCOGENE. 2004 DEC 9; 23 (57): 9238-9246

9962

9704 Kaur GP, Reddy DE, Zimonjic DB, de Riel JK, Athwal RS

Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells

ONCOGENE. 2005 JAN 6; 24 (1): 47-54

9963

9705 Delgado JP, Parouchev A, Allain JE, Pennarun L, Gauthier LR, et al.

Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer

ONCOGENE. 2005 JAN 20; 24 (4): 541-551

9964

9931 Tsuda M, Watanabe T, Seki T, Kimura T, Sawa H, et al.

Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1

ONCOGENE. 2005 DEC 1; 24 (54): 7984-7990

9965

10143 Helmbold H, Deppert W, Bohn W

Regulation of cellular senescence by Rb2/p130

ONCOGENE. 2006 AUG 28; 25 (38): 5257-5262

9966

10190 Macip S, Kosoy A, Lee SW, O'Connell MJ, Aaronson SA

Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G(2) checkpoint

ONCOGENE. 2006 OCT 5; 25 (45): 6037-6047

9967

10356 Yang G, Rosen DG, Colacino JA, Mercado-Uribe I, Liu J

Disruption of the retinoblastoma pathway by small interfering RNA and ectopic expression of the catalytic subunit of telomerase lead to immortalization of human ovarian surface epithelial cells

ONCOGENE. 2007 MAR 1; 26 (10): 1492-1498

9968

10402 Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, et al.

Role of 2-5A-dependent RNase-L in senescence and longevity

ONCOGENE. 2007 MAY 10; 26 (21): 3081-3088

9969

10568 Quereda V, Martinalbo J, Dubus P, Carnero A, Malumbres M

Genetic cooperation between p21(Cip1) and INK4 inhibitors in cellular senescence and tumor suppression

ONCOGENE. 2007 DEC 6; 26 (55): 7665-7674

9970

10670 Michaloglou C, Vredeveld LCW, Mooi WJ, Peeper DS

BRAF(E600) in benign and malignant human tumours

ONCOGENE. 2008 FEB 7; 27 (7): 877-895

209

Date / Author / Journal

LCS

GCS

LCR

9971

10881 Fridman AL, Tainsky MA

Critical pathways in cellular senescence and immortalization revealed by gene expression profiling

ONCOGENE. 2008 OCT 9; 27 (46): 5975-5987

129

9972

11094 Tilman G, Loriot A, Van Beneden A, Arnoult N, Londono-Vallejo JA, et al.

Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells

ONCOGENE. 2009 APR 9; 28 (14): 1682-1693

9973

11169 Wolyniec K, Wotton S, Kilbey A, Jenkins A, Terry A, et al.

RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress

ONCOGENE. 2009 JUL 9; 28 (27): 2502-2512

9974

11217 Sporn JC, Kustatscher G, Hothorn T, Collado M, Serrano M, et al.

Histone macroH2A isoforms predict the risk of lung cancer recurrence

ONCOGENE. 2009 SEP 24; 28 (38): 3423-3428

9975

11363 Lee JJ, Lee JH, Ko YG, Hong SI, Lee JS

Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species

ONCOGENE. 2010 JAN; 29 (4): 561-575

9976

11373 Novakova Z, Hubackova S, Kosar M, Janderova-Rossmeislova L, Dobrovolna J, et al.

Cytokine expression and signaling in drug-induced cellular senescence

ONCOGENE. 2010 JAN 14; 29 (2): 273-284

9977

11437 Varela E, Blasco MA

2009 Nobel Prize in Physiology or Medicine: telomeres and telomerase

ONCOGENE. 2010 MAR 18; 29 (11): 1561-1565

9978

11800 Das SK, Bhutia SK, Sokhi UK, Dash R, Azab B, et al.

Human polynucleotide phosphorylase (hPNPaseold(35)): an evolutionary conserved gene with an expanding repertoire of RNA degradation functions

ONCOGENE. 2011 APR; 30 (15): 1733-1743

9979

11827 Romagosa C, Simonetti S, Lopez-Vicente L, Mazo A, Lleonart ME, et al.

p16(Ink4a) overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors

ONCOGENE. 2011 MAY; 30 (18): 2087-2097

136

9980

11828 Rovillain E, Mansfield L, Caetano C, Alvarez-Fernandez M, Caballero OL, et al.

Activation of nuclear factor-kappa B signalling promotes cellular senescence

ONCOGENE. 2011 MAY; 30 (20): 2356-2366

Date / Author / Journal

LCS

GCS

LCR

9981

11848 Crescenzi E, Pacifico F, Lavorgna A, De Palma R, D'Aiuto E, et al.

NF-kappa B-dependent cytokine secretion controls Fas expression on chemotherapy-induced premature senescent tumor cells

ONCOGENE. 2011 JUN; 30 (24): 2707-2717

9982

11849 Lanigan F, Geraghty JG, Bracken AP

Transcriptional regulation of cellular senescence

ONCOGENE. 2011 JUN; 30 (26): 2901-2911

149

9983

5984 VOGT M, LESLEY J, BOGENBERGER JM, HAGGBLOM C, SWIFT S, et al.

THE INDUCTION OF GROWTH FACTOR-INDEPENDENCE IN MURINE MYELOCYTES BY ONCOGENES RESULTS IN MONOCLONAL CELL-LINES AND IS CORRELATED WITH CELL CRISIS AND KARYOTYPIC INSTABILITY

ONCOGENE RESEARCH. 1987; 2 (1): 49-63

9984

6323 OWEN TA, COSENZA SC, SOPRANO DR, SOPRANO KJ

EVIDENCE THAT STIMULATION OF GROWTH FOLLOWING LONG-TERM DENSITY ARREST OF WI-38 CELLS PROCEEDS VIA A PATHWAY INDEPENDENT OF PROTEIN KINASE-C AND OF CAMP-DEPENDENT PROTEIN-KINASE

ONCOGENE RESEARCH. 1989; 4 (2): 137-147

9985

7413 KILLARY AM, FOURNIER REK

MICROCELL FUSION

ONCOGENE TECHNIQUES. 1995; 254: 133-152

9986

10051 Ricci MS, Zong WX

Chemotherapeutic approaches for targeting cell death pathways

ONCOLOGIST. 2006 APR; 11 (4): 342-357

184

9987

2237 MOREK DM

ORGAN-CULTURE STUDY OF FROG RENAL TUMOR AND ITS EFFECTS ON NORMAL FROG KIDNEY IN-VITRO

ONCOLOGY. 1973; 28 (6): 536-552

9988

4349 DANES BS

HERITABLE COLONIC-CANCER SYNDROMES - INDUCTION OF ANCHORAGE- INDEPENDENCE IN DERMAL CULTURES DERIVED FROM PATIENTS WITH ADENOMATOSIS OF THE COLON AND RECTUM

ONCOLOGY. 1980; 37 (6): 386-389

9989

10395 Mayer DK, Terrin NC, Menon U, Kreps GL, McCance K, et al.

Health Behaviors in Cancer Survivors

ONCOLOGY NURSING FORUM. 2007 MAY; 34 (3): 643-651

9990

8155 Engelhardt M, Martens UM

The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review)

ONCOLOGY REPORTS. 1998 SEP-OCT; 5 (5): 1043-1052

109

Date / Author / Journal

LCS

GCS

LCR

9991

9232 Pandita TK, Roti JLR

Role of telomerase in radiocurability (Review)

ONCOLOGY REPORTS. 2003 MAR-APR; 10 (2): 263-270

9992

10413 Minami K, Inoue H, Terashita T, Kawakami T, Watanabe R, et al.

GADD34 induces p21 expression and cellular senescence

ONCOLOGY REPORTS. 2007 JUN; 17 (6): 1481-1485

9993

11563 Kim BC, Han NK, Byun HO, Kim SS, Ahn EK, et al.

Time-dependently expressed markers and the characterization for premature senescence induced by ionizing radiation in MCF7

ONCOLOGY REPORTS. 2010 AUG; 24 (2): 395-403

9994

7614 WynfordThomas D

Telomeres, p53 and cellular senescence

ONCOLOGY RESEARCH. 1996; 8 (10-11): 387-398

9995

6461 TRICHARD CJV, BASSON PA, VANDERLUGT JJ, JACOBSZ EP

AN OUTBREAK OF CONTAGIOUS BOVINE PLEUROPNEUMONIA IN THE OWAMBO MANGETTI AREA OF SOUTH-WEST-AFRICA NAMIBIA - MICROBIOLOGICAL, IMMUNOFLUORESCENT, PATHOLOGICAL AND SEROLOGICAL FINDINGS

ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH. 1989 DEC; 56 (4): 277-284

9996

7079 TRICHARD CJV, JORDAAN P, PROZESKY L, JACOBSZ EP, HENTON MM

THE IDENTIFICATION OF MYCOPLASMA-MYCOIDES-MYCOIDES LC AS THE ETIOLOGIC AGENT OF BALANOPOSTHITIS AND VULVO-VAGINITIS IN SHEEP IN SOUTH-AFRICA

ONDERSTEPOORT JOURNAL OF VETERINARY RESEARCH. 1993 MAR; 60 (1): 29-37

9997

8715 Sasgary S, Wieser M, Cerni C

Targeted inhibition of telomerase in human cancer: Will it be a double- edged sword?

ONKOLOGIE. 2001 FEB; 24 (1): 22-26

9998

4031 VORNHAGEN R, RINK H

INFLUENCE OF CULTURE CONDITIONS ON THE BEHAVIOR OF LENS EPITHELIAL- CELLS

OPHTHALMIC RESEARCH. 1979; 11 (5-6): 288-292

9999

8543 Rohrbach JM, Riedinger C, Wild M, Partsch M

Telomerase activity in uveal melanomas

OPHTHALMOLOGE. 2000 MAY; 97 (5): 359-363

10000

8467 Bron AJ, Vrensen GFJM, Koretz J, Maraini G, Harding JJ

The ageing lens

OPHTHALMOLOGICA. 2000 JAN-FEB; 214 (1): 86-104

129

Hayflick w/citing papers Len Hayflick publications & the papers citing L Hayflick.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 84164, GCS 458115, CR 564869 Collection span: 1953 - 2011
List of All Records